FDA recall D-0389-2024

Product

Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

Reason for recall

Cross Contamination with Other Products:(mycophenolate mofetil).

Distribution

Nationwide in the USA

Key facts

Status

Terminated

Initiation date

2024-03-04

Report date

2024-03-27

Termination date

2025-03-21

Voluntary/Mandated

Voluntary: Firm initiated

Location

East Windsor, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0389-2024